Clements J D, Lyon F L, Lowe K L, Farrand A L, el-Morshidy S
Infect Immun. 1986 Sep;53(3):685-92. doi: 10.1128/iai.53.3.685-692.1986.
We used Salmonella enteritidis serotype dublin strain SL1438, a nonreverting, aromatic-dependent, histidine-requiring mutant, as a recipient for a recombinant plasmid coding for production of the nontoxic B subunit of the heat-labile Escherichia coli enterotoxin. The S. enteritidis derivative EL23 produced heat-labile enterotoxin subunit B that was indistinguishable from heat-labile enterotoxin subunit B produced by strains of E. coli or Salmonella typhi harboring the same plasmid. Mice immunized orally with strain EL23 developed progressively increasing mucosal and serum antibody responses to both heat-labile enterotoxin subunit B and to the lipopolysaccharide of the vaccine strain. The mucosal antibody response was shown to be immunoglobulin A specific and to be capable of neutralizing the biological activities of both E. coli heat-labile enterotoxin and cholera enterotoxin in vitro.
我们使用肠炎沙门氏菌都柏林血清型菌株SL1438,这是一种非回复性、芳香族依赖性、需要组氨酸的突变体,作为编码不耐热大肠杆菌肠毒素无毒B亚基生产的重组质粒的受体。肠炎沙门氏菌衍生物EL23产生的不耐热肠毒素亚基B与携带相同质粒的大肠杆菌或伤寒沙门氏菌菌株产生的不耐热肠毒素亚基B无法区分。用EL23菌株口服免疫的小鼠对不耐热肠毒素亚基B和疫苗菌株的脂多糖产生了逐渐增强的黏膜和血清抗体反应。黏膜抗体反应显示为特异性免疫球蛋白A,并且能够在体外中和大肠杆菌不耐热肠毒素和霍乱肠毒素的生物活性。